Viking Therapeutics (NASDAQ: VKTX) shares exploded higher after the clinical-stage drugmaker announced successful results ...

The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...

Realising that the immune system could affect a hormone as vital as ... body's metabolic processes, using glucagon to increase glucose production and fuel their growth. In advanced liver cancer ...

Realising that the immune system could affect a hormone as vital as ... s metabolic processes, using glucagon to increase glucose production and fuel their growth. In advanced liver cancer ...

Realizing that the immune system could affect a hormone as vital as ... body's metabolic processes, using glucagon to increase glucose production and fuel their growth. In advanced liver cancer ...

Realizing that the immune system could affect a hormone as vital as ... s metabolic processes, using glucagon to increase glucose production and fuel their growth. In advanced liver cancer ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

GLP-1 agonists for weight loss are now commonly used for adults, but might they also be an effective treatment for younger people? Katharine Lang reports Obesity in children and adolescents is a ...

Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring ...

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to list on the Nasdaq under the symbol “BBNX.” ...